Identification of E2A target genes in B lymphocyte development by using a gene tagging-based chromatin immunoprecipitation system

被引:67
作者
Greenbaum, S [1 ]
Zhuang, Y [1 ]
机构
[1] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA
关键词
D O I
10.1073/pnas.232299999
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The transcription factors encoded by the E2A gene are known to be essential for B lymphocyte development, and ectopic expression or gene inactivation studies have revealed several potential lineage-specific E2A target genes. However, it remains unknown whether these target genes are directly regulated by E2A at the transcriptional level. We therefore generated mice carrying an affinity-tagged E2A knock-in allele to provide a system for the direct elucidation of E2A target genes based on E2A binding to target regulatory regions. Abelson-transformed pre-B cell lines derived from these mice were used in chromatin immunoprecipitation experiments to identify regulatory sequences bound by E2A in the context of an early B lymphocyte environment. Significant E2A binding was detected at the promoters and enhancers of several essential B-lineage genes, including the Igkappa intronic and 3' enhancers, lambda5 and VpreB surrogate light chain promoters, the EBF locus promoter region, and the mb-1 (Igalpha) promoter. Low levels of E2A binding were observed at several other lymphoid-restricted regulatory regions including the Ig heavy chain (IgH) intronic enhancer, the IgH 3' enhancers hs3b/hs4, the RAG-2 enhancer, and the 5' regions of the B29 and TdT loci. An E2A target gene, the predicted butyrophilin-like gene NG9 (BTL-II), was also identified by using a chromatin immunoprecipitation-based cloning strategy. In summary, our studies have provided evidence that E2A is directly involved in the transcriptional regulation of a number of early B-lineage genes.
引用
收藏
页码:15030 / 15035
页数:6
相关论文
共 38 条
[11]   Pax-5 (BSAP) recruits Ets proto-oncogene family proteins to form functional ternary complexes on a B-cell-specific promoter [J].
Fitzsimmons, D ;
Hodsdon, W ;
Wheat, W ;
Maira, SM ;
Wasylyk, B ;
Hagman, J .
GENES & DEVELOPMENT, 1996, 10 (17) :2198-2211
[12]   Localized gene-specific induction of accessibility to V(D)J recombination induced by E2A and early B cell factor in nonlymphoid cells [J].
Goebel, P ;
Janney, N ;
Valenzuela, JR ;
Romanow, WJ ;
Murre, C ;
Feeney, AJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (05) :645-656
[13]   2 DISTINCT TRANSCRIPTION FACTORS THAT BIND THE IMMUNOGLOBULIN ENHANCER MU-E5/KE2 MOTIF [J].
HENTHORN, P ;
KILEDJIAN, M ;
KADESCH, T .
SCIENCE, 1990, 247 (4941) :467-470
[14]   HEB, A HELIX-LOOP-HELIX PROTEIN RELATED TO E2A AND ITF2 THAT CAN MODULATE THE DNA-BINDING ABILITY OF MYOGENIC REGULATORY FACTORS [J].
HU, JS ;
OLSON, EN ;
KINGSTON, RE .
MOLECULAR AND CELLULAR BIOLOGY, 1992, 12 (03) :1031-1042
[15]   E2A EXPRESSION, NUCLEAR-LOCALIZATION, AND IN-VIVO FORMATION OF DNA-BINDING AND NON-DNA-BINDING SPECIES DURING B-CELL DEVELOPMENT [J].
JACOBS, Y ;
VIERRA, C ;
NELSON, C .
MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (12) :7321-7333
[16]   Induction of early B cell factor (EBF) and multiple B lineage genes by the basic helix-loop-helix transcription factor E12 [J].
Kee, BL ;
Murre, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (04) :699-713
[17]   IDENTIFICATION AND CHARACTERIZATION OF 2 FUNCTIONAL DOMAINS WITHIN THE MURINE HEAVY-CHAIN ENHANCER [J].
KILEDJIAN, M ;
SU, LK ;
KADESCH, T .
MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (01) :145-152
[18]   PROTEIN-BINDING SITES IN IG GENE ENHANCERS DETERMINE TRANSCRIPTIONAL ACTIVITY AND INDUCIBILITY [J].
LENARDO, M ;
PIERCE, JW ;
BALTIMORE, D .
SCIENCE, 1987, 236 (4808) :1573-1577
[19]   IDENTIFICATION OF A LOCUS-CONTROL REGION IN THE IMMUNOGLOBULIN HEAVY-CHAIN LOCUS THAT DEREGULATES C-MYC EXPRESSION IN PLASMACYTOMA AND BURKITTS-LYMPHOMA CELLS [J].
MADISEN, L ;
GROUDINE, M .
GENES & DEVELOPMENT, 1994, 8 (18) :2212-2226
[20]   An essential octamer motif in the mb-1 (Igα) promoter [J].
Malone, CS ;
Patrone, L ;
Wall, R .
MOLECULAR IMMUNOLOGY, 2000, 37 (06) :321-328